Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03207347
Title A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Florida
Indications

malignant mesothelioma

cholangiocarcinoma

renal cell carcinoma

uveal melanoma

Advanced Solid Tumor

Therapies

Niraparib

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST